The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Holista CollTech (HCT) has appointed Dr Arthur v. Martin to its Scientific Advisory Board
  • Arthur is currently the President and Principal Research Scientist of South Carolina based Global Infection Control Consultants and is behind the technology in Path-Away
  • Path-Away is an all-natural active ingredient that has been proven to be effective as a broad spectrum sanitizer
  • Holista currently has distribution rights for Path-Away in South East Asia, the United Kingdom and Europe
  • Holista is up 16.5 per cent on the market this morning, selling shares for 16.5¢ apiece

Holista CollTech (HCT) has appointed Dr Arthur v. Martin to its Scientific Advisory Board.

Arthur is currently the President and Principal Research Scientist of South Carolina based Global Infection Control Consultants (GICC LLC) and is behind the technology in Path-Away.

He graduated from the New England Institute of Technology where he studied HVAC (Heating, Ventilation and Air Conditioning) and Refrigeration Engineering.

Under his leadership, GICC LLC developed Path-Away, an all-natural active ingredient that has been proven to be effective as a broad spectrum sanitizer.

Holista currently has distribution rights for Path-Away in South East Asia, the United Kingdom and Europe. Sales of a sanitiser using Path-Away have increased significantly in Malaysia since the start of the year, following the coronavirus outbreak.

The Scientific Advisory Board is run by Roscoe Moore, a retired U.S. Deputy Surgeon General and earlier this month, Roscoe was appointed to the ‘Corona Virus Task Force’.

“I have been working with Dr Rajen and Holista for 15 years,” Arthur said.

“I humbly accept this appointment as scientific advisor to Holista and hope to bring my knowledge and expertise to use Path-Away to improve protection worldwide against viruses and the flu,” he added.

CEO Dr Rajen Manicka is thrilled to have Arthur join the Scientific Advisory Board.

“We intend to leverage on his network and expertise to increase the range of products and services using Path-Away. This will be a big boost to our sales and marketing efforts with Path-Away,” he said.

GICC LLC has designed specialised equipment and processes to use Path-Away to
improve the air quality and safety of buildings such as airports, transportation hubs, hospitals, schools and factories worldwide.

Holista is up 16.5 per cent on the market this morning, selling shares for 16.5¢ apiece at 11:23 am AEDT.

HCT by the numbers
More From The Market Online

BlinkLab partnership with US smart-tech Turning Pointe raises hopes for autism kids

BlinkLab partners with US-based Turning Pointe Autism Foundation for clinical study ahead of its FDA registration…

Little Green Pharma closely eyeing USA’s legal downgrade of Cannabis danger

Overnight, the Biden government did something sure to give their counterparts a stir – the USA…

OncoSil’s cancer device shows shrink in pancreatic tumours

OncoSil's cancer device shows shrink in pancreatic tumours at a study conducted at the Royal Adelaide…
The Market Online Video

Why Princeton Professor rates BlinkLab’s autism & ADHD screening app

In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and…